Brain Tumor Center: New & Noteworthy

Pictured: Moritz Kircher
New Technique for Imaging Brain Tumors Could Allow More Accurate Surgical Removal

Researchers have demonstrated a technique that enables specific and accurate labeling of brain tumor tissue in mice. If proven effective in patients, the method could make complete surgical removal of brain tumors more feasible.

Pictured: Moritz Kircher
Pictured: Moritz Kircher
Moritz Kircher Named Dana Neuroscience Scholar

Moritz Kircher, MD, PhD, has been selected by the directors of the Dana Foundation as a Dana Neuroscience Scholar.

Pictured: Moritz Kircher
Pictured: Moritz Kircher
Moritz F. Kircher Awarded the Dana Grant

Radiologist and molecular imaging researcher Moritz Kircher was awarded a Brain and Immuno-Imaging Grant by The Dana Foundation. This three-year grant supports the development of a dual-modality MRI-Raman nanoparticle that allows combined pre-and intra-operative visualization of glioblastomas.

Pictured: Moritz Kircher
Pictured: Antonio Omuro
Antonio Omuro Awarded the Cancer Clinical Investigator Team Leadership Award

Neurologist Antonio Omuro was awarded the highly prestigious Cancer Clinical Investigator Team Leadership Award by the National Cancer Institute. This award recognizes 11 exceptional clinical investigators for their contributions to the advancement of clinical research through collaborative team science.

Pictured: Antonio Omuro
Pictured: Eric Holland
NYC Scientists Unlocking the Brain's Power

Neurosurgeon Eric Holland, MD, PhD, offered his perspective on gliomas and highlighted new research at Memorial Sloan-Kettering’s Brain Tumor Center.

Pictured: Eric Holland
Neuroradiologist Robert Young Awarded RSNA Grant

New research funds have been awarded by the RSNA Research & Education Foundation to Robert Young, MD for Using Functional MRI and Diffusion Tensor Imaging of the Language Pathway to Optimize Brain Tumor Resection.

Pictured: Viviane Tabar
Researchers Show Brain Tumors Make Their Own Blood Vessels

Research led by neurosurgeon Viviane Tabar may help explain why brain tumors called glioblastomas are resistant to treatment.

Pictured: Viviane Tabar
A Target for Antiangiogenic Therapy

Adília Hormigo and colleagues published findings that antiangiogenic agents may block the growth of vascularized brain tumors.

Pictured: Eric C. Holland
Researchers Discover Genetic Changes That Make Some Forms of Brain Cancer More Aggressive Than Others

A multi-institutional team led by investigators from Memorial Sloan-Kettering Cancer Center has published a study that provides new insight into genetic changes that make some forms of glioblastoma, the most common type of primary brain cancer, more aggressive than others and explains why they may not respond to certain therapies.

Pictured: Eric C. Holland
Medulloblastoma Survivor Tell his Story

Matthew Penne, medulloblastoma survivor, tells his story in the summer issue of Bridges, our survivorship newsletter.